ProShares - UltraShort Nasdaq Biotechnology BIS · ETF Open ProShares - UltraShort Nasdaq Biotechnology in new tab
Weights
Sector Weights
Country Weights
ProShares - UltraShort Nasdaq Biotechnology Analysis (BIS)
Investment Objective: ProShares - UltraShort Nasdaq Biotechnology is an investment vehicle focused on the Financial Services sector in US. It is currently trading at 11.53 USD.
Portfolio Composition:
The fund is heavily weighted towards
the Cash & Others sector (100%)
and markets in
Other (100%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This appears to be an accumulating fund (dividends are reinvested) or focuses purely on capital growth.
Investor FAQ
Does ProShares - UltraShort Nasdaq Biotechnology pay a dividend?
No, it does not currently pay a dividend.
What asset class is ProShares - UltraShort Nasdaq Biotechnology?
ProShares - UltraShort Nasdaq Biotechnology is classified as a ETF. You can compare it against its peer in the "Related Symbols" list.
Fund Strategy
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain inverse leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.34 USD
|
| Sept. 30, 2027 (estimated) | 0.1390 |
| June 30, 2027 (estimated) | 0.1366 |
| March 29, 2027 (estimated) | 0.0686 |
| ▸2026 |
0.46 USD
|
| Dec. 31, 2026 (estimated) | 0.1203 |
| Sept. 29, 2026 | 0.1390 |
| June 30, 2026 | 0.1366 |
| March 31, 2026 | 0.0686 |
| ▸2025 |
0.50 USD
|
| Dec. 31, 2025 | 0.1026 |
| Sept. 30, 2025 | 0.1543 |
| July 1, 2025 | 0.1081 |
| April 1, 2025 | 0.1326 |
| ▸2024 |
0.68 USD
|
| Dec. 31, 2024 | 0.2064 |
| Oct. 2, 2024 | 0.1518 |
| July 3, 2024 | 0.1612 |
| March 27, 2024 | 0.1586 |
| ▸2023 |
0.32 USD
|
| Dec. 28, 2023 | 0.1759 |
| Sept. 27, 2023 | 0.1187 |
| June 28, 2023 | 0.0214 |
| ▸2020 |
0.07 USD
|
| April 1, 2020 | 0.0264 |
| Jan. 2, 2020 | 0.0413 |
| ▸2019 |
0.31 USD
|
| Oct. 2, 2019 | 0.0812 |
| July 2, 2019 | 0.0963 |
| March 27, 2019 | 0.0636 |
| Jan. 3, 2019 | 0.0679 |
| ▸2018 |
0.02 USD
|
| Oct. 3, 2018 | 0.0181 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| ProShares - UltraShort Nasdaq Biotechnology | Sep 29, 2026 | Paid | 0.139 USD |
| ProShares - UltraShort Nasdaq Biotechnology | Jun 30, 2026 | Paid | 0.1366 USD |
| ProShares - UltraShort Nasdaq Biotechnology | Mar 31, 2026 | Paid | 0.068568 USD |
| ProShares - UltraShort Nasdaq Biotechnology | Dec 31, 2025 | Paid | 0.10257 USD |
| Split Date | Split Ratio to 1 |
|---|---|
| Oct. 5, 2012 | 1:4 |
| Nov. 6, 2014 | 1:5 |
| Aug. 18, 2020 | 1:4 |
| May 28, 2026 | 1:2 |
Community Discussion